BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35659720)

  • 21. In vivo antitumor effects of chitosan-conjugated docetaxel after oral administration.
    Lee E; Kim H; Lee IH; Jon S
    J Control Release; 2009 Dec; 140(2):79-85. PubMed ID: 19712714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and therapeutic evaluation of an aptide-docetaxel conjugate targeting tumor-associated fibronectin.
    Kim H; Lee Y; Lee IH; Kim S; Kim D; Saw PE; Lee J; Choi M; Kim YC; Jon S
    J Control Release; 2014 Mar; 178():118-24. PubMed ID: 24462899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of novel biotinylated chitosan-decorated docetaxel-loaded nanocochleates for breast cancer targeting.
    Poudel I; Ahiwale R; Pawar A; Mahadik K; Bothiraja C
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):229-240. PubMed ID: 29575931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chitosan-based nanoparticle co-delivery of docetaxel and curcumin ameliorates anti-tumor chemoimmunotherapy in lung cancer.
    Zhu X; Yu Z; Feng L; Deng L; Fang Z; Liu Z; Li Y; Wu X; Qin L; Guo R; Zheng Y
    Carbohydr Polym; 2021 Sep; 268():118237. PubMed ID: 34127219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liposome-based co-delivery of siRNA and docetaxel for the synergistic treatment of lung cancer.
    Qu MH; Zeng RF; Fang S; Dai QS; Li HP; Long JT
    Int J Pharm; 2014 Oct; 474(1-2):112-22. PubMed ID: 25138252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyaluronic acid coated PLGA nanoparticulate docetaxel effectively targets and suppresses orthotopic human lung cancer.
    Wu J; Deng C; Meng F; Zhang J; Sun H; Zhong Z
    J Control Release; 2017 Aug; 259():76-82. PubMed ID: 28027947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of synthetic high-density lipoprotein-based ApoA-I mimetic peptide-loaded docetaxel as a drug delivery nanocarrier for breast cancer chemotherapy.
    Gong M; Zhang Q; Zhao Q; Zheng J; Li Y; Wang S; Yuan Y
    Drug Deliv; 2019 Dec; 26(1):708-716. PubMed ID: 31290708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liposomes co-Loaded with 6-Phosphofructo-2-Kinase/Fructose-2, 6-Biphosphatase 3 (PFKFB3) shRNA Plasmid and Docetaxel for the Treatment of non-small Cell Lung Cancer.
    Chowdhury N; Vhora I; Patel K; Doddapaneni R; Mondal A; Singh M
    Pharm Res; 2017 Nov; 34(11):2371-2384. PubMed ID: 28875330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Docetaxel-loaded solid lipid nanoparticles prevent tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells.
    da Rocha MCO; da Silva PB; Radicchi MA; Andrade BYG; de Oliveira JV; Venus T; Merker C; Estrela-Lopis I; Longo JPF; Báo SN
    J Nanobiotechnology; 2020 Mar; 18(1):43. PubMed ID: 32164731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced docetaxel delivery using sterically stabilized RIPL peptide-conjugated nanostructured lipid carriers: In vitro and in vivo antitumor efficacy against SKOV3 ovarian cancer cells.
    Kim CH; Kang TH; Kim BD; Lee TH; Yoon HY; Goo YT; Choi YS; Kang MJ; Choi YW
    Int J Pharm; 2020 Jun; 583():119393. PubMed ID: 32376445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD44-Targeted Multifunctional Nanomedicines Based on a Single-Component Hyaluronic Acid Conjugate with All-Natural Precursors: Construction and Treatment of Metastatic Breast Tumors
    Fang H; Zhao X; Gu X; Sun H; Cheng R; Zhong Z; Deng C
    Biomacromolecules; 2020 Jan; 21(1):104-113. PubMed ID: 31532629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Redox-responsive nanoparticles based on Chondroitin Sulfate and Docetaxel prodrug for tumor targeted delivery of Docetaxel.
    Li Y; Chen X; Ji J; Li L; Zhai G
    Carbohydr Polym; 2021 Mar; 255():117393. PubMed ID: 33436222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Docetaxel gold complex nanoflowers: A chemo-biological evaluation for their use as nanotherapeutics.
    Haddada MB; Movia D; Prina-Mello A; Spadavecchia J
    Colloids Surf B Biointerfaces; 2020 Oct; 194():111172. PubMed ID: 32534368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nimotuzumab increases chemosensitivity of human lung adenocarcinoma cell lines to docetaxel.
    Song HZ; Yi J; Chen J; Chen LB
    Oncol Res; 2012; 20(1):39-47. PubMed ID: 23035364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PD-L1-targeted microbubbles loaded with docetaxel produce a synergistic effect for the treatment of lung cancer under ultrasound irradiation.
    Li T; Hu Z; Wang C; Yang J; Zeng C; Fan R; Guo J
    Biomater Sci; 2020 Mar; 8(5):1418-1430. PubMed ID: 31942578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chrysin and Docetaxel Loaded Biodegradable Micelle for Combination Chemotherapy of Cancer Stem Cell.
    Ghamkhari A; Pouyafar A; Salehi R; Rahbarghazi R
    Pharm Res; 2019 Oct; 36(12):165. PubMed ID: 31646391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Keratin nanoparticles co-delivering Docetaxel and Chlorin e6 promote synergic interaction between chemo- and photo-dynamic therapies.
    Gaio E; Guerrini A; Ballestri M; Varchi G; Ferroni C; Martella E; Columbaro M; Moret F; Reddi E
    J Photochem Photobiol B; 2019 Oct; 199():111598. PubMed ID: 31465971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Folate-Targeted Cholesterol-Grafted Lipo-Polymeric Nanoparticles for Chemotherapeutic Agent Delivery.
    Sharma S; Pukale SS; Sahel DK; Agarwal DS; Dalela M; Mohanty S; Sakhuja R; Mittal A; Chitkara D
    AAPS PharmSciTech; 2020 Oct; 21(7):280. PubMed ID: 33037506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality of life results from the phase 3 REVEL randomized clinical trial of ramucirumab-plus-docetaxel versus placebo-plus-docetaxel in advanced/metastatic non-small cell lung cancer patients with progression after platinum-based chemotherapy.
    Pérol M; Ciuleanu TE; Arrieta O; Prabhash K; Syrigos KN; Goksel T; Park K; Kowalyszyn RD; Pikiel J; Lewanski CR; Thomas M; Dakhil S; Kim JH; Karaseva N; Yurasov S; Zimmermann A; Lee P; Carter GC; Reck M; Cappuzzo F; Garon EB
    Lung Cancer; 2016 Mar; 93():95-103. PubMed ID: 26898621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Core-matched nanoassemblies for targeted co-delivery of chemotherapy and photosensitizer to treat drug-resistant cancer.
    Jiang D; Xu M; Pei Y; Huang Y; Chen Y; Ma F; Lu H; Chen J
    Acta Biomater; 2019 Apr; 88():406-421. PubMed ID: 30763634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.